{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:17:55Z","timestamp":1783592275434,"version":"3.55.0"},"reference-count":27,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Hypoxia-inducible factor-1 alpha (HIF-1\u03b1) is a central regulator of cellular responses to hypoxia and has been implicated in the pathophysiology of several neurological disorders. Parkinson\u2019s disease (PD) and restless legs syndrome (RLS) have both been associated with alterations in oxygen sensing, mitochondrial dysfunction, and disturbances in amino acid metabolism; however, the relationship between HIF-1\u03b1 and amino acid metabolic pathways in these disorders remains incompletely understood. The present study investigated circulating HIF-1\u03b1 concentrations and amino acid metabolite profiles in patients with PD and RLS. Materials and Methods: In this cross-sectional study, 55 participants were enrolled, including 30 healthy controls, 12 patients with PD, and 13 patients with RLS. Plasma HIF-1\u03b1 concentrations were measured using an enzyme-linked immunosorbent assay, and amino acid metabolites were quantified by liquid chromatography\u2013tandem mass spectrometry. Group comparisons were performed using non-parametric methods with FDR correction. Age- and sex-adjusted regression analyses, correlation analyses, and PCA were used to assess metabolic relationships and group discrimination. Results: Significant group differences were observed for HIF-1\u03b1 and multiple amino acid metabolites. Compared with controls, both PD and RLS patients exhibited significantly higher concentrations of arginine, citrulline, homocitrulline, and HIF-1\u03b1, whereas ornithine concentrations were significantly lower. Arginine demonstrated the largest effect size among all biomarkers (\u03b52 = 0.713). HIF-1\u03b1 concentrations showed a progressive increase across groups, with the highest levels observed in RLS. Correlation analyses revealed strong positive associations of HIF-1\u03b1 with arginine, citrulline, and homocitrulline, and an inverse association with ornithine. These findings remained significant after adjustment for age and sex. PCA showed clear separation between controls and disease groups. Conclusions: PD and RLS are characterized by a shared metabolic signature involving elevated HIF-1\u03b1, increased arginine-pathway metabolites, and reduced ornithine concentrations. The detected associations between HIF-1\u03b1 and metabolites of the arginine\u2013citrulline\u2013ornithine pathway suggest a potential link between hypoxia-related signaling and metabolic dysregulation in both disorders. These findings support further investigation of HIF-1\u03b1-associated metabolic pathways as potential biomarkers and therapeutic targets in neurodegenerative and movement disorders.<\/jats:p>","DOI":"10.3390\/medicina62071312","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:00:32Z","timestamp":1783436432000},"page":"1312","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia-Associated Remodeling of the Arginine\u2013Citrulline\u2013Ornithine Axis in Parkinson\u2019s Disease and Restless Legs Syndrome: A Targeted LC\u2013MS\/MS and HIF-1\u03b1 Profiling Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8893-2926","authenticated-orcid":false,"given":"Seyma","family":"Dumur","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi Bagheri","family":"Asl","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of South Carolina,  135 Cannon Street, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet","family":"Aygun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Biruni University, 34295 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2362-7845","authenticated-orcid":false,"given":"Hafize","family":"Boyaci","sequence":"additional","affiliation":[{"name":"Fikret Biyal Central Biochemistry Laboratory, Istanbul University-Cerrahpasa, 34303 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dildar","family":"Konukoglu","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafize","family":"Uzun","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40035-016-0060-6","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"5","author":"Hu","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Guo, S., Huang, J., Jiang, H., Han, C., Li, J., Xu, X., Zhang, G., Lin, Z., Xiong, N., and Wang, T. (2017). Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management. Front. Aging Neurosci., 9.","DOI":"10.3389\/fnagi.2017.00171"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1002\/mds.21607","article-title":"The role of iron in restless legs syndrome","volume":"22","author":"Allen","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mds.27482","article-title":"Association of mitochondrial iron deficiency and dysfunction with idiopathic restless legs syndrome","volume":"34","author":"Haschka","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5603\/pjnns.109238","article-title":"Importance of hypoglycemia episodes and glycemic variability in parkinsonian syndromes","volume":"59","author":"Alster","year":"2025","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/physiol.00045.2008","article-title":"Regulation of oxygen homeostasis by hypoxia-inducible factor 1","volume":"24","author":"Semenza","year":"2009","journal-title":"Physiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1203\/00006450-200105000-00002","article-title":"Hypoxia-inducible factor 1: Control of oxygen homeostasis in health and disease","volume":"49","author":"Semenza","year":"2001","journal-title":"Pediatr. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1113\/jphysiol.2013.251470","article-title":"Oxygen sensing and hypoxia signalling pathways in animals: The implications of physiology for cancer","volume":"591","author":"Ratcliffe","year":"2013","journal-title":"J. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mitroshina, E.V., Savyuk, M.O., Ponimaskin, E., and Vedunova, M.V. (2021). Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.703084"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1007\/s00018-009-0141-0","article-title":"Contribution of hypoxia to Alzheimer\u2019s disease: Is HIF-1alpha a mediator of neurodegeneration?","volume":"66","author":"Ogunshola","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: Boundaries of our knowledge","volume":"137","author":"Morris","year":"2007","journal-title":"J. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: Nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1432-1033.1993.tb18122.x","article-title":"Intestinal arginine metabolism during development. Evidence for de novo synthesis of L-arginine in newborn pig enterocytes","volume":"216","author":"Blachier","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Havelund, J.F., Heegaard, N.H.H., F\u00e6rgeman, N.J.K., and Gramsbergen, J.B. (2017). Biomarker Research in Parkinson\u2019s Disease Using Metabolite Profiling. Metabolites, 7.","DOI":"10.3390\/metabo7030042"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Willkommen, D., Lucio, M., Moritz, F., Forcisi, S., Kanawati, B., Smirnov, K.S., Schroeter, M., Sigaroudi, A., Schmitt-Kopplin, P., and Michalke, B. (2018). Metabolomic investigations in cerebrospinal fluid of Parkinson\u2019s disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208752"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.3390\/ijms23116039","article-title":"Altered Brain Arginine Metabolism and Polyamine System in a P301S Tauopathy Mouse Model: A Time-Course Study","volume":"23","author":"Mein","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1152\/physrev.00039.2012","article-title":"Physiology and pathophysiology of carnosine","volume":"93","author":"Boldyrev","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hole\u010dek, M. (2020). Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement. Nutrients, 12.","DOI":"10.3390\/nu12030848"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-023-01569-3","article-title":"Amino acid metabolism in health and disease","volume":"8","author":"Ling","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.sleep.2016.07.028","article-title":"Iron and restless legs syndrome: Treatment, genetics and pathophysiology","volume":"31","author":"Connor","year":"2017","journal-title":"Sleep Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.mayocp.2020.12.026","article-title":"The Management of Restless Legs Syndrome: An Updated Algorithm","volume":"96","author":"Silber","year":"2021","journal-title":"Mayo Clin. Proc."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1312\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:32:29Z","timestamp":1783589549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071312"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071312","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}